AstraZeneca anticipates developing 200 million Covid-19 vaccine doses by 2020 end
AstraZeneca will have adequate vaccine doses for its potential candidate for 200 million doses, which will be available, by the end of 2020, and the additional upcoming planning of drug substance which will be 700 million doses till the first quarter of 2021 ends globally, Pam Cheng, operations executive revealed on Monday. In a briefing,…